Table 1:
Characteristics of melanoma cases and controls in the pooled Australian Melanoma Family Study and Leeds Melanoma Case-Control Study
| Controls n=975 (%) | Cases (N = 2,617) | |||||
|---|---|---|---|---|---|---|
| Head and Neck n=289 (%) | Trunk n=910 (%) | Upper-Limb n=525 (%) | Lower-Limb n=893 (%) | |||
| Study | ||||||
| Leeds | 505 (51.8) | 207 (71.6) | 699 (76.8) | 397 (75.6) | 710 (79.5) | |
| Australia | 470 (48.2) | 82 (28.4) | 211 (23.2) | 128 (28.4) | 183 (20.5) | |
| Sex | ||||||
| Male | 406 (41.6) | 158 (54.7) | 541 (59.5) | 187 (35.6) | 208 (23.3) | |
| Female | 569 (58.4) | 131 (45.3) | 369 (40.6) | 338 (64.4) | 685 (76.7) | |
| Age at diagnosis/interview (years) | ||||||
| 18–29 | 101 (10.4) | 47 (16.3) | 104 (11.4) | 46 (8.8) | 89 (10.0) | |
| 30–39 | 350 (35.9) | 63 (21.8) | 217 (23.9) | 137 (26.1) | 220 (24.6) | |
| 40–49 | 163 (16.8) | 19 (6.6) | 124 (13.6) | 88 (16.8) | 139 (15.6) | |
| 50–59 | 131 (13.4) | 42 (14.5) | 184 (20.2) | 87 (16.6) | 172 (19.3) | |
| 60–69 | 133 (13.6) | 58 (20.1) | 197 (21.7) | 117 (22.3) | 186 (20.8) | |
| ≥70 | 97 (9.9) | 60 (20.8) | 84 (9.2) | 50 (9.5) | 87 (9.7) | |
| Ethnic background | ||||||
| English | 740 (75.9) | 259 (89.6) | 775 (85.4) | 458 (87.6) | 784 (87.8) | |
| Scottish, Irish, Welsh | 39 (4.0) | 12 (4.2) | 50 (5.5) | 19 (3.6) | 51 (5.7) | |
| Other Northern European | 29 (3.0) | 2 (0.7) | 15 (1.7) | 6 (1.2) | 9 (1.0) | |
| Southern European | 10 (1.0) | 0 (0.0) | 6 (0.7) | 1 (0.2) | 1 (0.1) | |
| Eastern European | 132 (13.5) | 11 (3.8) | 48 (5.3) | 28 (5.4) | 38 (4.3) | |
| Mixed/Other European | 25 (2.6) | 5 (1.7) | 14 (1.5) | 11 (2.1) | 10 (1.1) | |
| Family history of melanoma (in a first-degree relative) | ||||||
| No | 919 (94.3) | 274 (94.8) | 815 (89.7) | 472 (89.9) | 821 (91.9) | |
| Yes | 56 (5.7) | 15 (5.2) | 94 (10.3) | 53 (10.1) | 72 (8.1) | |